Antiandrógeno no esteroideo (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antiandrógeno no esteroideo" in Spanish language version.

refsWebsite

Global rank Spanish rank

4^th place

2^nd place

6^th place

5^th place

archive.org

Kolvenbag, Geert J. C. M.; Furr, Barrington J. A. (2009). «Nonsteroidal Antiandrogens». En V. Craig Jordan; Barrington J. A. Furr, eds. Hormone Therapy in Breast and Prostate Cancer. Humana Press. pp. 347–368. ISBN 978-1-60761-471-5. doi:10.1007/978-1-59259-152-7_16.

Kolvenbag, Geert J. C. M.; Furr, Barrington J. A. (2009). «Nonsteroidal Antiandrogens». En V. Craig Jordan; Barrington J. A. Furr, eds. Hormone Therapy in Breast and Prostate Cancer. Humana Press. pp. 347–368. ISBN 978-1-60761-471-5. doi:10.1007/978-1-59259-152-7_16.
«Androgen receptor antagonists (antiandrogens): structure-activity relationships». Curr. Med. Chem. 7 (2): 211-47. 2000. PMID 10637363. doi:10.2174/0929867003375371.
«Update on idiopathic hirsutism: diagnosis and treatment». Acta Clin Belg 68 (4): 268-74. 2013. PMID 24455796. doi:10.2143/ACB.3267.
«Clinical practice. Care of transsexual persons». N. Engl. J. Med. 364 (13): 1251-7. 2011. PMID 21449788. doi:10.1056/NEJMcp1008161.
«Pharmacological options in the treatment of benign prostatic hyperplasia». J. Med. Chem. 40 (9): 1293-315. 1997. PMID 9135028. doi:10.1021/jm960697s.
«Insights of priapism mechanism and rationale treatment for recurrent priapism». Asian J. Androl. 10 (1): 88-101. 2008. PMID 18087648. doi:10.1111/j.1745-7262.2008.00314.x.

«Androgen receptor antagonists (antiandrogens): structure-activity relationships». Curr. Med. Chem. 7 (2): 211-47. 2000. PMID 10637363. doi:10.2174/0929867003375371.
«Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy». Arch Ital Urol Androl 71 (5): 293-302. 1999. PMID 10673793.
«Update on idiopathic hirsutism: diagnosis and treatment». Acta Clin Belg 68 (4): 268-74. 2013. PMID 24455796. doi:10.2143/ACB.3267.
«Clinical practice. Care of transsexual persons». N. Engl. J. Med. 364 (13): 1251-7. 2011. PMID 21449788. doi:10.1056/NEJMcp1008161.
«Pharmacological options in the treatment of benign prostatic hyperplasia». J. Med. Chem. 40 (9): 1293-315. 1997. PMID 9135028. doi:10.1021/jm960697s.
«Testotoxicosis: current viewpoint». Pediatr Endocrinol Rev 3 (2): 77-86. 2005. PMID 16361981.
«Insights of priapism mechanism and rationale treatment for recurrent priapism». Asian J. Androl. 10 (1): 88-101. 2008. PMID 18087648. doi:10.1111/j.1745-7262.2008.00314.x.